Pfizer CFO Dave Denton to Depart in August for New Industry Role
Summary
Pfizer's Chief Financial Officer, Dave Denton, will leave the company on August 15th to pursue another opportunity in the consumer-goods industry. Denton joined Pfizer in May 2022. Cecile Guegan, Senior Vice President of finance for its global biopharmaceutical business, will serve as interim CFO. The departure of a key executive like the CFO introduces a period of leadership transition and potential uncertainty for a company of Pfizer's size. The company plans an internal and external search for a permanent replacement.
At the time of this announcement, PFE was trading at $25.49 on NYSE in the Life Sciences sector, with a market capitalization of approximately $147.7B. The 52-week trading range was $23.11 to $28.75. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.